<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-57749" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Anti-NMDAR Encephalitis in Children</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Agarwal</surname>
            <given-names>Ritika</given-names>
          </name>
          <aff>Chandra Laxmi Hospital, Vaishali, Ghaziabad</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Gupta</surname>
            <given-names>Vikas</given-names>
          </name>
          <aff>Wellness Psychiatry P.C</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Ritika Agarwal declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Vikas Gupta declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>17</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-57749.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Anti NMDA receptor encephalitis is commonly confused with schizophrenia. Most of the available data on this illness is through published case reports. Although it has been newly recognized and understood, it is thought to be the more common cause of suspected demonic possession in childhood described throughout history as childhood-onset schizophrenia is very rare. Since there is more awareness about the symptoms, the pervasiveness of this form of encephalitis as a diagnosis has increased. This activity is an attempt to highlight the presentation, timeline of symptoms, key to diagnosis, and treatment of Anti NMDAR encephalitis in the pediatric population. Diagnostic clarity would expedite treatment leading to better outcomes.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Outline the clinical presentation in the various stages of anti-NMDAR encephalitis.</p></list-item><list-item><p>Identify the diagnostic clues to anti-NMDAR encephalitis.</p></list-item><list-item><p>Summarize the available treatment options for management in the pediatric population.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=57749&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=57749">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-57749.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Following the first report of pediatric anti-NMDAR encephalitis in China in 2010, &#x000a0;anti-<italic toggle="yes">N</italic>-methyl-d-aspartate receptor (anti-NMDAR) encephalitis is now recognized more frequently and commonly in the pediatric population. It is the second most common etiology for acute demyelinating encephalitis after mixed disturbance encephalitis surpassing all viral etiologies for encephalitis.<xref ref-type="bibr" rid="article-57749.r1">[1]</xref><xref ref-type="bibr" rid="article-57749.r2">[2]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-57749.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Anti-NMDAR encephalitis is an immune-mediated neuroinflammatory disease characterized by autoantibodies against the GluN1 subunit 2B (NR2B)/NMDA subunit 2A (NR2A) subunits of the NDMA receptor in the hippocampus causing the symptoms. Initially, it was diagnosed as a paraneoplastic disease most commonly associated with ovarian teratoma.<xref ref-type="bibr" rid="article-57749.r3">[3]</xref><xref ref-type="bibr" rid="article-57749.r4">[4]</xref><xref ref-type="bibr" rid="article-57749.r5">[5]</xref> However, published case reports show evidence of this association in only 31% of children &#x0003c;18 years and 9% of children under the age of 14 years.<xref ref-type="bibr" rid="article-57749.r5">[5]</xref><xref ref-type="bibr" rid="article-57749.r6">[6]</xref></p>
        <p>Another confirmed association has been seen with herpes simplex encephalitis.<xref ref-type="bibr" rid="article-57749.r7">[7]</xref> In a case series comprising of 99 patients, it was found out that 27% (64% NMDAR antibody positive) of the patients developed autoimmune encephalitis 2-16 weeks after herpes simplex encephalitis.<xref ref-type="bibr" rid="article-57749.r8">[8]</xref> Two studies suggest an association with HLA-I allele B*07:02 and HLA-II allele DRB1*16:02, however more evidential proof needs to be researched.<xref ref-type="bibr" rid="article-57749.r9">[9]</xref><xref ref-type="bibr" rid="article-57749.r10">[10]</xref></p>
        <p>In the California encephalitis project, it was found out that anti-NMDAR antibodies were produced in children post-infection with mycoplasma.<xref ref-type="bibr" rid="article-57749.r11">[11]</xref>&#x000a0;It was attributed to the body expressing a nonspecific immune response to the pathogens leading to antibodies directed against NMDAR. Therefore, it becomes necessary to screen for concomitant autoimmune encephalitis in an unusual presentation of viral encephalitis.<xref ref-type="bibr" rid="article-57749.r12">[12]</xref><xref ref-type="bibr" rid="article-57749.r13">[13]</xref></p>
      </sec>
      <sec id="article-57749.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Despite being recognized only 13 years ago and having an incidence of only 1.5 per million population per year, more than 1000 cases have been reported until now. It affects most age groups and both genders, with more incidence seen in females (75% cases).<xref ref-type="bibr" rid="article-57749.r4">[4]</xref><xref ref-type="bibr" rid="article-57749.r5">[5]</xref><xref ref-type="bibr" rid="article-57749.r14">[14]</xref><xref ref-type="bibr" rid="article-57749.r15">[15]</xref><xref ref-type="bibr" rid="article-57749.r16">[16]</xref><xref ref-type="bibr" rid="article-57749.r17">[17]</xref>&#x000a0;Literature shows that non-White race individuals have a higher risk of ovarian teratoma, hence the lifetime risk of getting anti-NMDAR encephalitis increases in these people.<xref ref-type="bibr" rid="article-57749.r14">[14]</xref> This association has been documented in the literature in individuals as young as three months of age.<xref ref-type="bibr" rid="article-57749.r18">[18]</xref><xref ref-type="bibr" rid="article-57749.r19">[19]</xref><xref ref-type="bibr" rid="article-57749.r20">[20]</xref></p>
      </sec>
      <sec id="article-57749.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>NMDAR is an excitatory glutamate receptor that, when activated, allows the passage of sodium and calcium ions through the channel. Activation occurs by the removal of magnesium plug, leading to glutamate and glycine binding to their respective sites.<xref ref-type="bibr" rid="article-57749.r21">[21]</xref></p>
        <p>Evidence suggests that these antibodies are produced in the CNS by antibody-producing cells that cross the blood-brain barrier.<xref ref-type="bibr" rid="article-57749.r22">[22]</xref> When antibodies bind to NMDAR, it causes internalization of these receptors from the cell surface leading to receptor hypofunction. The hypoactive receptors failed to cause tonic inhibition on the dopaminergic mesolimbic pathway resulting in psychosis.<xref ref-type="bibr" rid="article-57749.r21">[21]</xref></p>
        <p>Iizuka et al.&#x000a0;postulated that NMDAR is present in high density in the frontotemporal area, which atrophies in anti-NMDAR encephalitis leading to changes in behavior, learning, and memory.<xref ref-type="bibr" rid="article-57749.r23">[23]</xref>&#x000a0;Research utilizing a super-resolution microscopy model and Monte Carlo simulation found the importance of the interaction between NMDAR with other proteins (e.g., with EphB2R [ephrin-type B receptor 2] and other unknown interacting proteins).<xref ref-type="bibr" rid="article-57749.r24">[24]</xref>&#x000a0;Disruption of these interactions reproduced the observed clinical symptoms seen in patients. Drugs such as phencyclidine can mimic the symptoms of anti-NMDAR encephalitis as they are an antagonist at the receptor.</p>
      </sec>
      <sec id="article-57749.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Anti-NMDAR encephalitis has four clinical stages.<xref ref-type="bibr" rid="article-57749.r25">[25]</xref></p>
        <list list-type="order">
          <list-item>
            <p>Prodromal phase (phase 1): this stage is characterized by fever, headache, nausea, vomiting, and upper respiratory tract infection-like symptoms.<xref ref-type="bibr" rid="article-57749.r3">[3]</xref><xref ref-type="bibr" rid="article-57749.r26">[26]</xref><xref ref-type="bibr" rid="article-57749.r27">[27]</xref>&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Illness phase (phase 2): During this stage, MRI abnormalities or pleocytosis can be seen, which decreases over several weeks without any visible changes in the symptoms.<xref ref-type="bibr" rid="article-57749.r6">[6]</xref> These findings are strikingly different from the cytotoxic CD8 + T cell-mediated encephalitis, where there is an extensive neuronal loss.<xref ref-type="bibr" rid="article-57749.r28">[28]</xref>
<list list-type="bullet"><list-item><p>Psychiatric phase- This phase lasts for 1&#x000a0;to 2 weeks. Children present with behavioral changes, irritability, tantrums, coma, manic symptoms, behavioral outbursts, sleep dysfunction, and hyperactivity.</p></list-item><list-item><p>Neurological phase- This phase lasts for weeks to months. Children present with seizures (focal, motor, complex partial), dystonia, or status epilepticus.<xref ref-type="bibr" rid="article-57749.r29">[29]</xref> Within weeks, changes in speech and language (mutism and decreased responsiveness) can be seen. Catatonia, cardiac arrhythmia, autonomic instability, hypoventilation, and uncoordinated respiration occur, which requires ICU admission. Speech dysfunction is much more commonly seen in children than autonomic dysfunction and hyperventilation.<xref ref-type="bibr" rid="article-57749.r26">[26]</xref><xref ref-type="bibr" rid="article-57749.r30">[30]</xref> Motor dysfunction, in addition to the typical seizures, can develop as dyskinetic movements such as orofacial dyskinesia. Young children can have ataxia or difficulty walking and even lose the ability to walk.</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Recovery phase (phase 3): Recovery has been described in the reverse order of the presentation of symptoms.<xref ref-type="bibr" rid="article-57749.r6">[6]</xref> The slowest to improve are the cognitive and psychiatric functions.<xref ref-type="bibr" rid="article-57749.r25">[25]</xref> With appropriate immunotherapy and multidisciplinary care, the patients can enter the recovery phase after a few months of treatment. The presence of inflammation on MRI and CSF is minimal.&#x000a0;Antibodies can persist even after complete recovery.<xref ref-type="bibr" rid="article-57749.r31">[31]</xref></p>
          </list-item>
          <list-item>
            <p>Late phase (phase 4): The majority of the patients make a full recovery of cognition and behavioral abnormality at the time of hospital discharge.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-57749.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Every child should be tested for herpes simplex virus (HSV) and other viral etiology testing can be based on time of year and geographical location. Diagnostic clues for diagnosing anti- NMDAR encephalitis are shown in figure 1. Confirmation of the clinical diagnosis requires demonstration of IgG antibodies against the GluN1 subunit of NMDAR in the serum or CSF sample.<xref ref-type="bibr" rid="article-57749.r15">[15]</xref><xref ref-type="bibr" rid="article-57749.r32">[32]</xref> CSF sample also demonstrates lymphocytic pleocytosis, the elevation of proteins, and CSF-specific oligoclonal bands.<xref ref-type="bibr" rid="article-57749.r33">[33]</xref><xref ref-type="bibr" rid="article-57749.r3">[3]</xref>&#x000a0; &#x000a0; &#x000a0;</p>
        <p>Brain MRI demonstrates bilateral T2 or FLAIR signal hyperintensities in hippocampi, frontal cortex, medial temporal lobe, cerebellar cortex, spinal cord, and medulla oblongata.<xref ref-type="bibr" rid="article-57749.r34">[34]</xref> However, these findings were evident in only 30% of the patients in the study conducted by Titulaer et al.<xref ref-type="bibr" rid="article-57749.r35">[35]</xref>&#x000a0;Most commonly, the lesions present in the hippocampus, and therefore it is the main predictor of poor prognosis in patients.</p>
        <p>Electroencephalography shows a slow continuous rhythmic and disorganized activity in delta and theta range superimposed seizures,&#x000a0;as 90% of patients have&#x000a0;a slowing of EEG at some point during the illness.<xref ref-type="bibr" rid="article-57749.r5">[5]</xref><xref ref-type="bibr" rid="article-57749.r35">[35]</xref></p>
      </sec>
      <sec id="article-57749.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Autonomic dysfunction, hyperventilation, cardiac arrhythmia, or hyperkinetic crisis can occur in children presenting with neurological symptoms. These children should be managed in the ICU. First-line treatment involves teratoma resection (if present), immunotherapy comprising of corticosteroids, intravenous immunoglobulins or plasma exchange, and supportive care.<xref ref-type="bibr" rid="article-57749.r25">[25]</xref><xref ref-type="bibr" rid="article-57749.r32">[32]</xref> Second-line treatment (table 1) using rituximab or cyclophosphamide is most often necessary when the patient does not have an underlying tumor.<xref ref-type="bibr" rid="article-57749.r4">[4]</xref><xref ref-type="bibr" rid="article-57749.r3">[3]</xref><xref ref-type="bibr" rid="article-57749.r5">[5]</xref><xref ref-type="bibr" rid="article-57749.r36">[36]</xref>&#x000a0;Relapse is more common in patients without a tumor; therefore, continued immunosuppression is recommended for at least one year using drugs such as mycophenolate mofetil or azathioprine.<xref ref-type="bibr" rid="article-57749.r5">[5]</xref><xref ref-type="bibr" rid="article-57749.r14">[14]</xref><xref ref-type="bibr" rid="article-57749.r32">[32]</xref>&#x000a0;</p>
        <p>Clonidine, trazodone, and benzodiazepines help to reverse sleep disturbances. Phenobarbital, trihexyphenidyl, and opioids can treat extreme agitation.<xref ref-type="bibr" rid="article-57749.r37">[37]</xref><xref ref-type="bibr" rid="article-57749.r38">[38]</xref><xref ref-type="bibr" rid="article-57749.r39">[39]</xref><xref ref-type="bibr" rid="article-57749.r40">[40]</xref>&#x000a0;Methotrimeprazine or dexmedetomidine infusion prove beneficial for children with refractory agitation. Benzodiazepines manage the catatonic symptoms. A daily dose of up to 20-30 milligrams of lorazepam can be given to patients. In the absence of a response to benzodiazepines, electroconvulsive therapy can be a treatment option.<xref ref-type="bibr" rid="article-57749.r41">[41]</xref><xref ref-type="bibr" rid="article-57749.r42">[42]</xref> In animal models, electroconvulsive therapy has been shown to upregulate the NMDR.<xref ref-type="bibr" rid="article-57749.r43">[43]</xref></p>
        <p>Psychotic and behavioral symptoms are managed using typical or atypical antipsychotics. Severe dopamine blockage can exacerbate dyskinetic movements. The development of neuroleptic malignant syndrome may occur, which can complicate and misdiagnose anti NMDAR encephalitis. Quetiapine is the drug of choice for treating psychosis. Valproate works as an excellent mood stabilizer and also offers seizure prophylaxis. Gabapentin and lithium can also be used for mood dysregulation.<xref ref-type="bibr" rid="article-57749.r38">[38]</xref><xref ref-type="bibr" rid="article-57749.r39">[39]</xref><xref ref-type="bibr" rid="article-57749.r44">[44]</xref></p>
        <p>If children show no improvement with any of the above treatment modalities, mechanical ventilation, and ketamine or propofol infusion can be considered. Children under the age of 5 years are at a higher risk of precipitating propofol infusion syndrome. Vigilant laboratory surveillance is needed in children receiving propofol for longer than 24 hours.<xref ref-type="bibr" rid="article-57749.r45">[45]</xref><xref ref-type="bibr" rid="article-57749.r46">[46]</xref><xref ref-type="bibr" rid="article-57749.r47">[47]</xref>&#x000a0;Noise reduction can help to avoid agitation. Muscle relaxants concomitant to corticosteroid therapy should be avoided in children&#x000a0;in order to prevent myopathies.<xref ref-type="bibr" rid="article-57749.r48">[48]</xref></p>
        <p>Resting tachycardia is one of the most common autonomic and hemodynamic instability seen in the pediatric population suffering from anti-NMDAR encephalitis.<xref ref-type="bibr" rid="article-57749.r3">[3]</xref><xref ref-type="bibr" rid="article-57749.r5">[5]</xref><xref ref-type="bibr" rid="article-57749.r29">[29]</xref> Bradycardia is associated with seizures in the pediatric age group; hence round the clock, EEG is essential. Medications such as glycopyrrolate or theophylline have been shown to prevent severe bradycardia.<xref ref-type="bibr" rid="article-57749.r49">[49]</xref> Autonomic dysfunction can manifest as fluctuating temperature and blood pressure dysregulation. Movement disorders exacerbate during a febrile state; it is essential to maintain and aggressive temperature control using antipyretics and cooling blankets.</p>
        <p>In the third week, placement of tracheostomy and gastrostomy tubes have shown to improve patient safety and also allows to switch to lesser sedation. Once feasible, it becomes of the utmost importance, that a comprehensive rehabilitation program is begun.<xref ref-type="bibr" rid="article-57749.r50">[50]</xref><xref ref-type="bibr" rid="article-57749.r51">[51]</xref><xref ref-type="bibr" rid="article-57749.r52">[52]</xref>&#x000a0;Rehabilitation should include physical therapy, occupational therapy, and speech therapy.</p>
      </sec>
      <sec id="article-57749.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The condition can be presented to either a neurologist or a psychiatrist. The following should be considered as differentials: Drug abuse, post-infectious syndromes (viral, <italic toggle="yes">Mycoplasma</italic>, pediatric autoimmune neuropsychiatric disorders associated with Streptococcal infections). Acquired reversible autistic syndrome in acute encephalopathic illness in children, immune-mediated chorea encephalopathy syndrome in childhood, acute diffuse lymphocytic meningoencephalitis, acute reversible limbic encephalitis, acute juvenile non-herpetic encephalitis, acute disseminated encephalomyelitis (ADEM), inborn errors of metabolism (including urea cycle disorders), environmental toxins and medication overdose, rheumatological conditions such as neuropsychiatric lupus and primary psychiatric conditions such as schizophrenia. Due to the extensive differential diagnosis, the patient&#x02019;s diagnostic workup should be individualized.</p>
      </sec>
      <sec id="article-57749.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>In the research, Dalmau showed that 75% of the patients with NMDAR encephalitis recover entirely or with mild sequelae while the other 25% have severe CNS deficits or eventually die.<xref ref-type="bibr" rid="article-57749.r3">[3]</xref> Some other studies have identified a similar history and symptoms in the preceding months of diagnosis, indicating that there is a lifetime risk of 12% to 24% for relapse.<xref ref-type="bibr" rid="article-57749.r53">[53]</xref><xref ref-type="bibr" rid="article-57749.r54">[54]</xref>&#x000a0;</p>
        <p>In a study using the data obtained from 382 patients aged between 1 to 85 years, Balu et al. devised a five-point predictions score, Anti-NMDAR encephalitis 1-year functioning status (NEOS) score.<xref ref-type="bibr" rid="article-57749.r22">[22]</xref> This score uses five variables, which account for one point each. The variables are ICU admission, treatment delay of greater than four weeks, lack of clinical improvement within four weeks, abnormal MRI, and CSF WBC count higher than 20 microlitres. A score of zero or one was associated with a 3% chance of having poor functional status at one year.<xref ref-type="bibr" rid="article-57749.r22">[22]</xref>&#x000a0; A score of 4 or 5 was associated with 69% chances of having a poor functional condition at the end of 1 year.<xref ref-type="bibr" rid="article-57749.r22">[22]</xref>&#x000a0;1-year functional status is of great importance to physicians and healthcare providers when they are discussing the prognosis with family members.</p>
      </sec>
      <sec id="article-57749.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Early identification and treatment have been shown to cause less damage to the hippocampus, yet the optimal time window between symptom onset and treatment initiation is still not identified.<xref ref-type="bibr" rid="article-57749.r55">[55]</xref> Dalmau has reported in his research that recovery develops as a multistage process that occurs in the reverse order of the appearance of symptoms.<xref ref-type="bibr" rid="article-57749.r32">[32]</xref></p>
      </sec>
      <sec id="article-57749.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>A careful look at the symptoms and identification of IgG antibodies in CSF is vital to prevent misdiagnosis in patients presenting with anti-NMDAR encephalitis. No specific biomarker exists to predict the outcomes for this encephalitis. Therefore, the dissemination of knowledge about this disorder is required for better patient outcomes.</p>
      </sec>
      <sec id="article-57749.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Child neurologists must work in a timely manner to facilitate early screening and diagnosis. Management of patients in ICU requires a multidisciplinary approach from a team comprising of neurologists, psychiatrists, nutritionists, and physical therapists. Arrangements should be made for social workers, pastoral care, and child life experts to be actively involved in care as children and families find that helpful.</p>
        <p>Anti NMDAR encephalitis can be easily diagnosed using serum or CSF sample testing. An index of suspicion should be raised in children, presenting with personality changes, abnormal movements or postures, seizures, autonomic instability, or hypoventilation. It poses considerable difficulty in early diagnosis and treatment. Management may also prove to be clinically challenging as it involves treating both the cause and the symptoms.</p>
        <p>The recovery is slow; hence, long-term monitoring is required by an interprofessional team consisting of doctors, and social workers would help decreasing morbidity tremendously.&#x000a0;A continuous&#x000a0;follow-up by the rehabilitation and neurology team is essential. A psychiatry consultation might be needed for both patients and family members in order to cope during the recovery. Interdisciplinary communication and collaboration are quintessential to good patient outcomes with this condition.</p>
      </sec>
      <sec id="article-57749.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=57749&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=57749">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/child-health/anti-nmdar-encephalitis-in-children/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=57749">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/57749/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=57749">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-57749.s15">
        <fig id="article-57749.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Clues to diagnose anti NMDAR encephalitis in patients presenting with new acute onset of psychosis. Contributed by Ritika Agarwal, Adapted from Dalmua et al 2019</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Slide1" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-57749.s16">
        <fig id="article-57749.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Table describing the proposed therapy for treatment of Anti NMDAR encephalitis along with dosage. Contributed by Ritika Agarwal, Adapted from Remy et al (2017)</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="WINWORD_5mQWPqYtPT" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-57749.s17">
        <title>References</title>
        <ref id="article-57749.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Xu</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>WQ</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>DX</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>MY</given-names>
              </name>
              <name>
                <surname>Qiao</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>JW</given-names>
              </name>
            </person-group>
            <article-title>Anti-N-methyl-D-aspartate receptor encephalitis with serum anti-thyroid antibodies and IgM antibodies against Epstein-Barr virus viral capsid antigen: a case report and one year follow-up.</article-title>
            <source>BMC Neurol</source>
            <year>2011</year>
            <month>Nov</month>
            <day>29</day>
            <volume>11</volume>
            <fpage>149</fpage>
            <pub-id pub-id-type="pmid">22126669</pub-id>
          </element-citation>
        </ref>
        <ref id="article-57749.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gable</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Sheriff</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Dalmau</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Tilley</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Glaser</surname>
                <given-names>CA</given-names>
              </name>
            </person-group>
            <article-title>The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project.</article-title>
            <source>Clin Infect Dis</source>
            <year>2012</year>
            <month>Apr</month>
            <volume>54</volume>
            <issue>7</issue>
            <fpage>899</fpage>
            <page-range>899-904</page-range>
            <pub-id pub-id-type="pmid">22281844</pub-id>
          </element-citation>
        </ref>
        <ref id="article-57749.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dalmau</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Gleichman</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Hughes</surname>
                <given-names>EG</given-names>
              </name>
              <name>
                <surname>Rossi</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Peng</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Lai</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Dessain</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Rosenfeld</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Balice-Gordon</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lynch</surname>
                <given-names>DR</given-names>
              </name>
            </person-group>
            <article-title>Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies.</article-title>
            <source>Lancet Neurol</source>
            <year>2008</year>
            <month>Dec</month>
            <volume>7</volume>
            <issue>12</issue>
            <fpage>1091</fpage>
            <page-range>1091-8</page-range>
            <pub-id pub-id-type="pmid">18851928</pub-id>
          </element-citation>
        </ref>
        <ref id="article-57749.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dalmau</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>T&#x000fc;z&#x000fc;n</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>HY</given-names>
              </name>
              <name>
                <surname>Masjuan</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Rossi</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Voloschin</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Baehring</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Shimazaki</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Koide</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>King</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Mason</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Sansing</surname>
                <given-names>LH</given-names>
              </name>
              <name>
                <surname>Dichter</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Rosenfeld</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Lynch</surname>
                <given-names>DR</given-names>
              </name>
            </person-group>
            <article-title>Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma.</article-title>
            <source>Ann Neurol</source>
            <year>2007</year>
            <month>Jan</month>
            <volume>61</volume>
            <issue>1</issue>
            <fpage>25</fpage>
            <page-range>25-36</page-range>
            <pub-id pub-id-type="pmid">17262855</pub-id>
          </element-citation>
        </ref>
        <ref id="article-57749.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Florance</surname>
                <given-names>NR</given-names>
              </name>
              <name>
                <surname>Davis</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Lam</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Szperka</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Zhou</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Ahmad</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Campen</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Moss</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Peter</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Gleichman</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Glaser</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Lynch</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Rosenfeld</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Dalmau</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents.</article-title>
            <source>Ann Neurol</source>
            <year>2009</year>
            <month>Jul</month>
            <volume>66</volume>
            <issue>1</issue>
            <fpage>11</fpage>
            <page-range>11-8</page-range>
            <pub-id pub-id-type="pmid">19670433</pub-id>
          </element-citation>
        </ref>
        <ref id="article-57749.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Florance-Ryan</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Dalmau</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Update on anti-N-methyl-D-aspartate receptor encephalitis in children and adolescents.</article-title>
            <source>Curr Opin Pediatr</source>
            <year>2010</year>
            <month>Dec</month>
            <volume>22</volume>
            <issue>6</issue>
            <fpage>739</fpage>
            <page-range>739-44</page-range>
            <pub-id pub-id-type="pmid">21045695</pub-id>
          </element-citation>
        </ref>
        <ref id="article-57749.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nosadini</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mohammad</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Corazza</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ruga</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Kothur</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Perilongo</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Frigo</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Toldo</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Dale</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Sartori</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Herpes simplex virus-induced anti-N-methyl-d-aspartate receptor encephalitis: a systematic literature review with analysis of 43 cases.</article-title>
            <source>Dev Med Child Neurol</source>
            <year>2017</year>
            <month>Aug</month>
            <volume>59</volume>
            <issue>8</issue>
            <fpage>796</fpage>
            <page-range>796-805</page-range>
            <pub-id pub-id-type="pmid">28439890</pub-id>
          </element-citation>
        </ref>
        <ref id="article-57749.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Armangue</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Spatola</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Vlagea</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mattozzi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>C&#x000e1;rceles-Cordon</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Martinez-Heras</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Llufriu</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Muchart</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Erro</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Abraira</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Moris</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Monros-Gim&#x000e9;nez</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Corral-Corral</surname>
                <given-names>&#x000cd;</given-names>
              </name>
              <name>
                <surname>Montejo</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Toledo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bataller</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Secondi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ari&#x000f1;o</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Mart&#x000ed;nez-Hern&#x000e1;ndez</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Juan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Marcos</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Alsina</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Saiz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rosenfeld</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Graus</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Dalmau</surname>
                <given-names>J</given-names>
              </name>
              <collab>Spanish Herpes Simplex Encephalitis Study Group</collab>
            </person-group>
            <article-title>Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis.</article-title>
            <source>Lancet Neurol</source>
            <year>2018</year>
            <month>Sep</month>
            <volume>17</volume>
            <issue>9</issue>
            <fpage>760</fpage>
            <page-range>760-772</page-range>
            <pub-id pub-id-type="pmid">30049614</pub-id>
          </element-citation>
        </ref>
        <ref id="article-57749.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mueller</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>F&#x000e4;rber</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pr&#x000fc;ss</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Melzer</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Golombeck</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>K&#x000fc;mpfel</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Thaler</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Elisak</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lewerenz</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kaufmann</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>S&#x000fc;hs</surname>
                <given-names>KW</given-names>
              </name>
              <name>
                <surname>Ringelstein</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kellinghaus</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bien</surname>
                <given-names>CG</given-names>
              </name>
              <name>
                <surname>Kraft</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Zettl</surname>
                <given-names>UK</given-names>
              </name>
              <name>
                <surname>Ehrlich</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Handreka</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Rost&#x000e1;sy</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Then Bergh</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Faiss</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Lieb</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Franke</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kuhlenb&#x000e4;umer</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Wandinger</surname>
                <given-names>KP</given-names>
              </name>
              <name>
                <surname>Leypoldt</surname>
                <given-names>F</given-names>
              </name>
              <collab>German Network for Research on Autoimmune Encephalitis (GENERATE)</collab>
            </person-group>
            <article-title>Genetic predisposition in anti-LGI1 and anti-NMDA receptor encephalitis.</article-title>
            <source>Ann Neurol</source>
            <year>2018</year>
            <month>Apr</month>
            <volume>83</volume>
            <issue>4</issue>
            <fpage>863</fpage>
            <page-range>863-869</page-range>
            <pub-id pub-id-type="pmid">29572931</pub-id>
          </element-citation>
        </ref>
        <ref id="article-57749.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Qiu</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Zheng</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Yin</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Yue</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Deng</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Peng</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Lu</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Hu</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Petersen</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Yu</surname>
                <given-names>X</given-names>
              </name>
            </person-group>
            <article-title>HLA class II allele <italic>DRB1*16:02</italic> is associated with anti-NMDAR encephalitis.</article-title>
            <source>J Neurol Neurosurg Psychiatry</source>
            <year>2019</year>
            <month>Jun</month>
            <volume>90</volume>
            <issue>6</issue>
            <fpage>652</fpage>
            <page-range>652-658</page-range>
            <pub-id pub-id-type="pmid">30636700</pub-id>
          </element-citation>
        </ref>
        <ref id="article-57749.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>DuBray</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Anglemyer</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>LaBeaud</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Flori</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Bloch</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Joaquin</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>Messenger</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Preas</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Sheriff</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Glaser</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Epidemiology, outcomes and predictors of recovery in childhood encephalitis: a hospital-based study.</article-title>
            <source>Pediatr Infect Dis J</source>
            <year>2013</year>
            <month>Aug</month>
            <volume>32</volume>
            <issue>8</issue>
            <fpage>839</fpage>
            <page-range>839-44</page-range>
            <pub-id pub-id-type="pmid">23518823</pub-id>
          </element-citation>
        </ref>
        <ref id="article-57749.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Borlot</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Santos</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Bandeira</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Liberalesso</surname>
                <given-names>PB</given-names>
              </name>
              <name>
                <surname>Kok</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>L&#x000f6;hr</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Reed</surname>
                <given-names>UC</given-names>
              </name>
            </person-group>
            <article-title>Anti-N-methyl D-aspartate receptor encephalitis in childhood.</article-title>
            <source>J Pediatr (Rio J)</source>
            <year>2012</year>
            <month>May</month>
            <volume>88</volume>
            <issue>3</issue>
            <fpage>275</fpage>
            <page-range>275-8</page-range>
            <pub-id pub-id-type="pmid">22456689</pub-id>
          </element-citation>
        </ref>
        <ref id="article-57749.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shruthi</surname>
                <given-names>TK</given-names>
              </name>
              <name>
                <surname>Shuba</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rajakumar</surname>
                <given-names>PS</given-names>
              </name>
              <name>
                <surname>Chitrambalam</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Anti-NMDA receptor encephalitis in an adolescent.</article-title>
            <source>Indian Pediatr</source>
            <year>2014</year>
            <month>May</month>
            <volume>51</volume>
            <issue>5</issue>
            <fpage>405</fpage>
            <page-range>405-6</page-range>
            <pub-id pub-id-type="pmid">24953589</pub-id>
          </element-citation>
        </ref>
        <ref id="article-57749.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mann</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Machado</surname>
                <given-names>NM</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Mazin</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Silver</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Afzal</surname>
                <given-names>KI</given-names>
              </name>
            </person-group>
            <article-title>A multidisciplinary approach to the treatment of anti-NMDA-receptor antibody encephalitis: a case and review of the literature.</article-title>
            <source>J Neuropsychiatry Clin Neurosci</source>
            <year>2012</year>
            <season>Spring</season>
            <volume>24</volume>
            <issue>2</issue>
            <fpage>247</fpage>
            <page-range>247-54</page-range>
            <pub-id pub-id-type="pmid">22772674</pub-id>
          </element-citation>
        </ref>
        <ref id="article-57749.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Irani</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Vincent</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>NMDA receptor antibody encephalitis.</article-title>
            <source>Curr Neurol Neurosci Rep</source>
            <year>2011</year>
            <month>Jun</month>
            <volume>11</volume>
            <issue>3</issue>
            <fpage>298</fpage>
            <page-range>298-304</page-range>
            <pub-id pub-id-type="pmid">21331529</pub-id>
          </element-citation>
        </ref>
        <ref id="article-57749.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Granerod</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ambrose</surname>
                <given-names>HE</given-names>
              </name>
              <name>
                <surname>Davies</surname>
                <given-names>NW</given-names>
              </name>
              <name>
                <surname>Clewley</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Walsh</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Morgan</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Cunningham</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Zuckerman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mutton</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Solomon</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ward</surname>
                <given-names>KN</given-names>
              </name>
              <name>
                <surname>Lunn</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Irani</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Vincent</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Crowcroft</surname>
                <given-names>NS</given-names>
              </name>
              <collab>UK Health Protection Agency (HPA) Aetiology of Encephalitis Study Group</collab>
            </person-group>
            <article-title>Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study.</article-title>
            <source>Lancet Infect Dis</source>
            <year>2010</year>
            <month>Dec</month>
            <volume>10</volume>
            <issue>12</issue>
            <fpage>835</fpage>
            <page-range>835-44</page-range>
            <pub-id pub-id-type="pmid">20952256</pub-id>
          </element-citation>
        </ref>
        <ref id="article-57749.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Peery</surname>
                <given-names>HE</given-names>
              </name>
              <name>
                <surname>Day</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Doja</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Xia</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Fritzler</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Foster</surname>
                <given-names>WG</given-names>
              </name>
            </person-group>
            <article-title>Anti-NMDA receptor encephalitis in children: the disorder, its diagnosis, and treatment.</article-title>
            <source>Handb Clin Neurol</source>
            <year>2013</year>
            <volume>112</volume>
            <fpage>1229</fpage>
            <page-range>1229-33</page-range>
            <pub-id pub-id-type="pmid">23622333</pub-id>
          </element-citation>
        </ref>
        <ref id="article-57749.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Desena</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Graves</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Warnack</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Greenberg</surname>
                <given-names>BM</given-names>
              </name>
            </person-group>
            <article-title>Herpes simplex encephalitis as a potential cause of anti-N-methyl-D-aspartate receptor antibody encephalitis: report of 2 cases.</article-title>
            <source>JAMA Neurol</source>
            <year>2014</year>
            <month>Mar</month>
            <volume>71</volume>
            <issue>3</issue>
            <fpage>344</fpage>
            <page-range>344-6</page-range>
            <pub-id pub-id-type="pmid">24473671</pub-id>
          </element-citation>
        </ref>
        <ref id="article-57749.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Irani</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Bera</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Waters</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Zuliani</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Maxwell</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Zandi</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Friese</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Galea</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Kullmann</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Beeson</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Lang</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Bien</surname>
                <given-names>CG</given-names>
              </name>
              <name>
                <surname>Vincent</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes.</article-title>
            <source>Brain</source>
            <year>2010</year>
            <month>Jun</month>
            <volume>133</volume>
            <issue>Pt 6</issue>
            <fpage>1655</fpage>
            <page-range>1655-67</page-range>
            <pub-id pub-id-type="pmid">20511282</pub-id>
          </element-citation>
        </ref>
        <ref id="article-57749.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dale</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Irani</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Brilot</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Pillai</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Webster</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Gill</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Lang</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Vincent</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>N-methyl-D-aspartate receptor antibodies in pediatric dyskinetic encephalitis lethargica.</article-title>
            <source>Ann Neurol</source>
            <year>2009</year>
            <month>Nov</month>
            <volume>66</volume>
            <issue>5</issue>
            <fpage>704</fpage>
            <page-range>704-9</page-range>
            <pub-id pub-id-type="pmid">19938173</pub-id>
          </element-citation>
        </ref>
        <ref id="article-57749.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lakhan</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Caro</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hadzimichalis</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>NMDA Receptor Activity in Neuropsychiatric Disorders.</article-title>
            <source>Front Psychiatry</source>
            <year>2013</year>
            <volume>4</volume>
            <fpage>52</fpage>
            <pub-id pub-id-type="pmid">23772215</pub-id>
          </element-citation>
        </ref>
        <ref id="article-57749.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Balu</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>McCracken</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Lancaster</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Graus</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Dalmau</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Titulaer</surname>
                <given-names>MJ</given-names>
              </name>
            </person-group>
            <article-title>A score that predicts 1-year functional status in patients with anti-NMDA receptor encephalitis.</article-title>
            <source>Neurology</source>
            <year>2019</year>
            <month>Jan</month>
            <day>15</day>
            <volume>92</volume>
            <issue>3</issue>
            <fpage>e244</fpage>
            <page-range>e244-e252</page-range>
            <pub-id pub-id-type="pmid">30578370</pub-id>
          </element-citation>
        </ref>
        <ref id="article-57749.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Iizuka</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Sakai</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ide</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Monzen</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Yoshii</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Iigaya</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Suzuki</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Lynch</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Suzuki</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Hata</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Dalmau</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal.</article-title>
            <source>Neurology</source>
            <year>2008</year>
            <month>Feb</month>
            <day>12</day>
            <volume>70</volume>
            <issue>7</issue>
            <fpage>504</fpage>
            <page-range>504-11</page-range>
            <pub-id pub-id-type="pmid">17898324</pub-id>
          </element-citation>
        </ref>
        <ref id="article-57749.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lad&#x000e9;p&#x000ea;che</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Planagum&#x000e0;</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Thakur</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Su&#x000e1;rez</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Hara</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Borbely</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Sandoval</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Laparra-Cuervo</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Dalmau</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lakadamyali</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>NMDA Receptor Autoantibodies in Autoimmune Encephalitis Cause a Subunit-Specific Nanoscale Redistribution of NMDA Receptors.</article-title>
            <source>Cell Rep</source>
            <year>2018</year>
            <month>Jun</month>
            <day>26</day>
            <volume>23</volume>
            <issue>13</issue>
            <fpage>3759</fpage>
            <page-range>3759-3768</page-range>
            <pub-id pub-id-type="pmid">29949761</pub-id>
          </element-citation>
        </ref>
        <ref id="article-57749.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kayser</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Dalmau</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Anti-NMDA Receptor Encephalitis in Psychiatry.</article-title>
            <source>Curr Psychiatry Rev</source>
            <year>2011</year>
            <volume>7</volume>
            <issue>3</issue>
            <fpage>189</fpage>
            <page-range>189-193</page-range>
            <pub-id pub-id-type="pmid">24729779</pub-id>
          </element-citation>
        </ref>
        <ref id="article-57749.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gable</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Gavali</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Radner</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tilley</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Dyner</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Collins</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dengel</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dalmau</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Glaser</surname>
                <given-names>CA</given-names>
              </name>
            </person-group>
            <article-title>Anti-NMDA receptor encephalitis: report of ten cases and comparison with viral encephalitis.</article-title>
            <source>Eur J Clin Microbiol Infect Dis</source>
            <year>2009</year>
            <month>Dec</month>
            <volume>28</volume>
            <issue>12</issue>
            <fpage>1421</fpage>
            <page-range>1421-9</page-range>
            <pub-id pub-id-type="pmid">19718525</pub-id>
          </element-citation>
        </ref>
        <ref id="article-57749.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Luca</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Daengsuwan</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Dalmau</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>deVeber</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Kobayashi</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Laxer</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Benseler</surname>
                <given-names>SM</given-names>
              </name>
            </person-group>
            <article-title>Anti-N-methyl-D-aspartate receptor encephalitis: a newly recognized inflammatory brain disease in children.</article-title>
            <source>Arthritis Rheum</source>
            <year>2011</year>
            <month>Aug</month>
            <volume>63</volume>
            <issue>8</issue>
            <fpage>2516</fpage>
            <page-range>2516-22</page-range>
            <pub-id pub-id-type="pmid">21547896</pub-id>
          </element-citation>
        </ref>
        <ref id="article-57749.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dalmau</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Graus</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Antibody-Mediated Encephalitis.</article-title>
            <source>N Engl J Med</source>
            <year>2018</year>
            <month>Mar</month>
            <day>01</day>
            <volume>378</volume>
            <issue>9</issue>
            <fpage>840</fpage>
            <page-range>840-851</page-range>
            <pub-id pub-id-type="pmid">29490181</pub-id>
          </element-citation>
        </ref>
        <ref id="article-57749.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Armangue</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Titulaer</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>M&#x000e1;laga</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Bataller</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Gabilondo</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Graus</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Dalmau</surname>
                <given-names>J</given-names>
              </name>
              <collab>Spanish Anti-N-methyl-D-Aspartate Receptor (NMDAR) Encephalitis Work Group</collab>
            </person-group>
            <article-title>Pediatric anti-N-methyl-D-aspartate receptor encephalitis-clinical analysis and novel findings in a series of 20 patients.</article-title>
            <source>J Pediatr</source>
            <year>2013</year>
            <month>Apr</month>
            <volume>162</volume>
            <issue>4</issue>
            <fpage>850</fpage>
            <page-range>850-856.e2</page-range>
            <pub-id pub-id-type="pmid">23164315</pub-id>
          </element-citation>
        </ref>
        <ref id="article-57749.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moscato</surname>
                <given-names>EH</given-names>
              </name>
              <name>
                <surname>Jain</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Peng</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Hughes</surname>
                <given-names>EG</given-names>
              </name>
              <name>
                <surname>Dalmau</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Balice-Gordon</surname>
                <given-names>RJ</given-names>
              </name>
            </person-group>
            <article-title>Mechanisms underlying autoimmune synaptic encephalitis leading to disorders of memory, behavior and cognition: insights from molecular, cellular and synaptic studies.</article-title>
            <source>Eur J Neurosci</source>
            <year>2010</year>
            <month>Jul</month>
            <volume>32</volume>
            <issue>2</issue>
            <fpage>298</fpage>
            <page-range>298-309</page-range>
            <pub-id pub-id-type="pmid">20646055</pub-id>
          </element-citation>
        </ref>
        <ref id="article-57749.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dalmau</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Geis</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Graus</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Autoantibodies to Synaptic Receptors and Neuronal Cell Surface Proteins in Autoimmune Diseases of the Central Nervous System.</article-title>
            <source>Physiol Rev</source>
            <year>2017</year>
            <month>Apr</month>
            <volume>97</volume>
            <issue>2</issue>
            <fpage>839</fpage>
            <page-range>839-887</page-range>
            <pub-id pub-id-type="pmid">28298428</pub-id>
          </element-citation>
        </ref>
        <ref id="article-57749.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dalmau</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lancaster</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Martinez-Hernandez</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Rosenfeld</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Balice-Gordon</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis.</article-title>
            <source>Lancet Neurol</source>
            <year>2011</year>
            <month>Jan</month>
            <volume>10</volume>
            <issue>1</issue>
            <fpage>63</fpage>
            <page-range>63-74</page-range>
            <pub-id pub-id-type="pmid">21163445</pub-id>
          </element-citation>
        </ref>
        <ref id="article-57749.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Barry</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Hardiman</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Healy</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Keogan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Moroney</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Molnar</surname>
                <given-names>PP</given-names>
              </name>
              <name>
                <surname>Cotter</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Murphy</surname>
                <given-names>KC</given-names>
              </name>
            </person-group>
            <article-title>Anti-NMDA receptor encephalitis: an important differential diagnosis in psychosis.</article-title>
            <source>Br J Psychiatry</source>
            <year>2011</year>
            <month>Dec</month>
            <volume>199</volume>
            <issue>6</issue>
            <fpage>508</fpage>
            <page-range>508-9</page-range>
            <pub-id pub-id-type="pmid">21984802</pub-id>
          </element-citation>
        </ref>
        <ref id="article-57749.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rosenfeld</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Dalmau</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Paraneoplastic Neurologic Syndromes.</article-title>
            <source>Neurol Clin</source>
            <year>2018</year>
            <month>Aug</month>
            <volume>36</volume>
            <issue>3</issue>
            <fpage>675</fpage>
            <page-range>675-685</page-range>
            <pub-id pub-id-type="pmid">30072076</pub-id>
          </element-citation>
        </ref>
        <ref id="article-57749.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Titulaer</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>McCracken</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Gabilondo</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Armangu&#x000e9;</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Glaser</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Iizuka</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Honig</surname>
                <given-names>LS</given-names>
              </name>
              <name>
                <surname>Benseler</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Kawachi</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Martinez-Hernandez</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Aguilar</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Gresa-Arribas</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Ryan-Florance</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Torrents</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Saiz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rosenfeld</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Balice-Gordon</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Graus</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Dalmau</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study.</article-title>
            <source>Lancet Neurol</source>
            <year>2013</year>
            <month>Feb</month>
            <volume>12</volume>
            <issue>2</issue>
            <fpage>157</fpage>
            <page-range>157-65</page-range>
            <pub-id pub-id-type="pmid">23290630</pub-id>
          </element-citation>
        </ref>
        <ref id="article-57749.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kashyape</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Taylor</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Ng</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Krishnakumar</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kirkham</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Whitney</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Successful treatment of two paediatric cases of anti-NMDA receptor encephalitis with cyclophosphamide: the need for early aggressive immunotherapy in tumour negative paediatric patients.</article-title>
            <source>Eur J Paediatr Neurol</source>
            <year>2012</year>
            <month>Jan</month>
            <volume>16</volume>
            <issue>1</issue>
            <fpage>74</fpage>
            <page-range>74-8</page-range>
            <pub-id pub-id-type="pmid">21831679</pub-id>
          </element-citation>
        </ref>
        <ref id="article-57749.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Raha</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gadgil</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sankhla</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Udani</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Nonparaneoplastic anti-N-methyl-D-aspartate receptor encephalitis: a case series of four children.</article-title>
            <source>Pediatr Neurol</source>
            <year>2012</year>
            <month>Apr</month>
            <volume>46</volume>
            <issue>4</issue>
            <fpage>246</fpage>
            <page-range>246-9</page-range>
            <pub-id pub-id-type="pmid">22490772</pub-id>
          </element-citation>
        </ref>
        <ref id="article-57749.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hung</surname>
                <given-names>TY</given-names>
              </name>
              <name>
                <surname>Foo</surname>
                <given-names>NH</given-names>
              </name>
              <name>
                <surname>Lai</surname>
                <given-names>MC</given-names>
              </name>
            </person-group>
            <article-title>Anti-N-methyl-d-aspartate receptor encephalitis.</article-title>
            <source>Pediatr Neonatol</source>
            <year>2011</year>
            <month>Dec</month>
            <volume>52</volume>
            <issue>6</issue>
            <fpage>361</fpage>
            <page-range>361-4</page-range>
            <pub-id pub-id-type="pmid">22192267</pub-id>
          </element-citation>
        </ref>
        <ref id="article-57749.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kuo</surname>
                <given-names>YL</given-names>
              </name>
              <name>
                <surname>Tsai</surname>
                <given-names>HF</given-names>
              </name>
              <name>
                <surname>Lai</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>YK</given-names>
              </name>
            </person-group>
            <article-title>Anti-NMDA receptor encephalitis with the initial presentation of psychotic mania.</article-title>
            <source>J Clin Neurosci</source>
            <year>2012</year>
            <month>Jun</month>
            <volume>19</volume>
            <issue>6</issue>
            <fpage>896</fpage>
            <page-range>896-8</page-range>
            <pub-id pub-id-type="pmid">22330692</pub-id>
          </element-citation>
        </ref>
        <ref id="article-57749.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jones</surname>
                <given-names>KC</given-names>
              </name>
              <name>
                <surname>Schwartz</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Hermida</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Kahn</surname>
                <given-names>DA</given-names>
              </name>
            </person-group>
            <article-title>A Case of Anti-NMDA Receptor Encephalitis Treated with ECT.</article-title>
            <source>J Psychiatr Pract</source>
            <year>2015</year>
            <month>Sep</month>
            <volume>21</volume>
            <issue>5</issue>
            <fpage>374</fpage>
            <page-range>374-80</page-range>
            <pub-id pub-id-type="pmid">26348805</pub-id>
          </element-citation>
        </ref>
        <ref id="article-57749.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dhossche</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Fink</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Shorter</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Wachtel</surname>
                <given-names>LE</given-names>
              </name>
            </person-group>
            <article-title>Anti-NMDA receptor encephalitis versus pediatric catatonia.</article-title>
            <source>Am J Psychiatry</source>
            <year>2011</year>
            <month>Jul</month>
            <volume>168</volume>
            <issue>7</issue>
            <fpage>749</fpage>
            <page-range>749-50; author reply 750</page-range>
            <pub-id pub-id-type="pmid">21724675</pub-id>
          </element-citation>
        </ref>
        <ref id="article-57749.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dhossche</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Wachtel</surname>
                <given-names>LE</given-names>
              </name>
            </person-group>
            <article-title>Catatonia is hidden in plain sight among different pediatric disorders: a review article.</article-title>
            <source>Pediatr Neurol</source>
            <year>2010</year>
            <month>Nov</month>
            <volume>43</volume>
            <issue>5</issue>
            <fpage>307</fpage>
            <page-range>307-15</page-range>
            <pub-id pub-id-type="pmid">20933172</pub-id>
          </element-citation>
        </ref>
        <ref id="article-57749.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Watkins</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Pei</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Newberry</surname>
                <given-names>NR</given-names>
              </name>
            </person-group>
            <article-title>Differential effects of electroconvulsive shock on the glutamate receptor mRNAs for NR2A, NR2B and mGluR5b.</article-title>
            <source>Brain Res Mol Brain Res</source>
            <year>1998</year>
            <month>Oct</month>
            <day>30</day>
            <volume>61</volume>
            <issue>1-2</issue>
            <fpage>108</fpage>
            <page-range>108-13</page-range>
            <pub-id pub-id-type="pmid">9795172</pub-id>
          </element-citation>
        </ref>
        <ref id="article-57749.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kuppuswamy</surname>
                <given-names>PS</given-names>
              </name>
              <name>
                <surname>Takala</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Sola</surname>
                <given-names>CL</given-names>
              </name>
            </person-group>
            <article-title>Management of psychiatric symptoms in anti-NMDAR encephalitis: a case series, literature review and future directions.</article-title>
            <source>Gen Hosp Psychiatry</source>
            <year>2014</year>
            <season>Jul-Aug</season>
            <volume>36</volume>
            <issue>4</issue>
            <fpage>388</fpage>
            <page-range>388-91</page-range>
            <pub-id pub-id-type="pmid">24731834</pub-id>
          </element-citation>
        </ref>
        <ref id="article-57749.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Reed</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Yamashita</surname>
                <given-names>TS</given-names>
              </name>
              <name>
                <surname>Marx</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Myers</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Blumer</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>A pharmacokinetically based propofol dosing strategy for sedation of the critically ill, mechanically ventilated pediatric patient.</article-title>
            <source>Crit Care Med</source>
            <year>1996</year>
            <month>Sep</month>
            <volume>24</volume>
            <issue>9</issue>
            <fpage>1473</fpage>
            <page-range>1473-81</page-range>
            <pub-id pub-id-type="pmid">8797618</pub-id>
          </element-citation>
        </ref>
        <ref id="article-57749.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bray</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Propofol infusion in children.</article-title>
            <source>Crit Care Med</source>
            <year>2000</year>
            <month>Jun</month>
            <volume>28</volume>
            <issue>6</issue>
            <fpage>2177</fpage>
            <page-range>2177-8</page-range>
            <pub-id pub-id-type="pmid">10890707</pub-id>
          </element-citation>
        </ref>
        <ref id="article-57749.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bray</surname>
                <given-names>RJ</given-names>
              </name>
            </person-group>
            <article-title>Propofol infusion for ICU sedation in children.</article-title>
            <source>Anaesthesia</source>
            <year>2002</year>
            <month>May</month>
            <volume>57</volume>
            <issue>5</issue>
            <fpage>521</fpage>
            <pub-id pub-id-type="pmid">12004826</pub-id>
          </element-citation>
        </ref>
        <ref id="article-57749.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Deem</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Intensive-care-unit-acquired muscle weakness.</article-title>
            <source>Respir Care</source>
            <year>2006</year>
            <month>Sep</month>
            <volume>51</volume>
            <issue>9</issue>
            <fpage>1042</fpage>
            <page-range>1042-52; discussion 1052-3</page-range>
            <pub-id pub-id-type="pmid">16934167</pub-id>
          </element-citation>
        </ref>
        <ref id="article-57749.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sadaka</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Naydenov</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Ponzillo</surname>
                <given-names>JJ</given-names>
              </name>
            </person-group>
            <article-title>Theophylline for bradycardia secondary to cervical spinal cord injury.</article-title>
            <source>Neurocrit Care</source>
            <year>2010</year>
            <month>Dec</month>
            <volume>13</volume>
            <issue>3</issue>
            <fpage>389</fpage>
            <page-range>389-92</page-range>
            <pub-id pub-id-type="pmid">20878263</pub-id>
          </element-citation>
        </ref>
        <ref id="article-57749.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bradley</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Rehabilitation following anti-NMDA encephalitis.</article-title>
            <source>Brain Inj</source>
            <year>2015</year>
            <volume>29</volume>
            <issue>6</issue>
            <fpage>785</fpage>
            <page-range>785-8</page-range>
            <pub-id pub-id-type="pmid">25626115</pub-id>
          </element-citation>
        </ref>
        <ref id="article-57749.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Houtrow</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Bhandal</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pratini</surname>
                <given-names>NR</given-names>
              </name>
              <name>
                <surname>Davidson</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Neufeld</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>The rehabilitation of children with anti-N-methyl-D-aspartate-receptor encephalitis: a case series.</article-title>
            <source>Am J Phys Med Rehabil</source>
            <year>2012</year>
            <month>May</month>
            <volume>91</volume>
            <issue>5</issue>
            <fpage>435</fpage>
            <page-range>435-41</page-range>
            <pub-id pub-id-type="pmid">22415341</pub-id>
          </element-citation>
        </ref>
        <ref id="article-57749.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Remy</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>Custer</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Cappell</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Foster</surname>
                <given-names>CB</given-names>
              </name>
              <name>
                <surname>Garber</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Walker</surname>
                <given-names>LK</given-names>
              </name>
              <name>
                <surname>Simon</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bagdure</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Pediatric Anti-<italic>N</italic>-Methyl-d-Aspartate Receptor Encephalitis: A Review with Pooled Analysis and Critical Care Emphasis.</article-title>
            <source>Front Pediatr</source>
            <year>2017</year>
            <volume>5</volume>
            <fpage>250</fpage>
            <pub-id pub-id-type="pmid">29226117</pub-id>
          </element-citation>
        </ref>
        <ref id="article-57749.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chapman</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Vause</surname>
                <given-names>HE</given-names>
              </name>
            </person-group>
            <article-title>Anti-NMDA receptor encephalitis: diagnosis, psychiatric presentation, and treatment.</article-title>
            <source>Am J Psychiatry</source>
            <year>2011</year>
            <month>Mar</month>
            <volume>168</volume>
            <issue>3</issue>
            <fpage>245</fpage>
            <page-range>245-51</page-range>
            <pub-id pub-id-type="pmid">21368306</pub-id>
          </element-citation>
        </ref>
        <ref id="article-57749.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gabilondo</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Saiz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gal&#x000e1;n</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Gonz&#x000e1;lez</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Jadraque</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sabater</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Sans</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sempere</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Vela</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Villalobos</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Vi&#x000f1;als</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Villoslada</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Graus</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Analysis of relapses in anti-NMDAR encephalitis.</article-title>
            <source>Neurology</source>
            <year>2011</year>
            <month>Sep</month>
            <day>06</day>
            <volume>77</volume>
            <issue>10</issue>
            <fpage>996</fpage>
            <page-range>996-9</page-range>
            <pub-id pub-id-type="pmid">21865579</pub-id>
          </element-citation>
        </ref>
        <ref id="article-57749.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Finke</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kopp</surname>
                <given-names>UA</given-names>
              </name>
              <name>
                <surname>Pr&#x000fc;ss</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Dalmau</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wandinger</surname>
                <given-names>KP</given-names>
              </name>
              <name>
                <surname>Ploner</surname>
                <given-names>CJ</given-names>
              </name>
            </person-group>
            <article-title>Cognitive deficits following anti-NMDA receptor encephalitis.</article-title>
            <source>J Neurol Neurosurg Psychiatry</source>
            <year>2012</year>
            <month>Feb</month>
            <volume>83</volume>
            <issue>2</issue>
            <fpage>195</fpage>
            <page-range>195-8</page-range>
            <pub-id pub-id-type="pmid">21933952</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
